MEI Pharma (NASDAQ:MEIP) has launched a $100 million Litecoin (CRYPTO: LTC) treasury program, backed by Titan Partners Group ...

Attention remains on large-cap tokens on Friday as crypto bills’ approval fueled crypto rallies. While Ethereum steadied ...

MEI Pharma raises $100 million to buy Litecoin, boosting stock value and signaling confidence in LTC's future growth.

MEI Pharma, a publicly traded pharmaceutical company, closed a $100 million private placement to turn itself into a litecoin ...

“This initiative represents the first time a public company is aligning its treasury strategy with Litecoin at an ...

MEI Pharma unveils bold $100M Litecoin treasury plan with Titan, GSR, Litecoin Foundation, expanding altcoin adoption beyond ...

MEI Pharma announces a $100 million private placement to adopt Litecoin as its primary treasury reserve asset.

MEI Pharma commits $100M to Litecoin with Charlie Lee joining its board, signaling major institutional interest in LTC.

Tracing the weekly technical analysis, Litecoin has broken through the 55-EMA and 200-EMA—two indicators often used by medium ...

MEI Pharma ( (MEIP)) has issued an update. On July 17, 2025, MEI Pharma entered into securities purchase agreements for a private placement offering, raising approximately $100 million to initiate a ...

How companies like MicroStrategy and SharpLink are using crypto treasury strategies to reshape corporate finance with bitcoin ...